Results 251 to 260 of about 343,067 (338)
Endothelial Cell Organization Drives Distinct Agonist-Specific Ca<sup>2+</sup> Dynamics in Arteries and Veins. [PDF]
Lee MD +6 more
europepmc +1 more source
Characterizing Perinatal Treatment Patterns and Outcomes in Myasthenia Gravis
ABSTRACT Introduction/Aims Studies on pregnancy in myasthenia gravis (MG) are limited by small sample sizes or examine a limited number of outcomes. The objective of this study was to estimate the prevalence of perinatal and infant outcomes and characterize perinatal treatment patterns in MG.
Melanie H. Jacobson +11 more
wiley +1 more source
Scorpion Venom Heat-Resistant Synthetic Peptide Alleviates DSS-Induced Colitis via α7nAChR-Mediated Modulation of the JAK2/STAT3 Pathway. [PDF]
Cheng K +9 more
europepmc +1 more source
Chemical and biological controls and soil amendments for plant‐parasitic nematode management
This review synthesizes sustainable strategies for managing plant‐parasitic nematodes, emphasizing eco‐friendly biocontrol agents and soil amendments. It critically evaluates the impacts of chemical nematicides on nontarget soil organisms and advocates integrated approaches to enhance soil health, crop productivity, and agricultural sustainability ...
Zhongling Tian +6 more
wiley +1 more source
Through network pharmacology and molecular docking, it has been discovered that CA can target MAOB, among other proteins, to exert a therapeutic effect in IBS. In vivo, CA lowered visceral hypersensitivity, anxiety and depression‐like behaviors, and fecal water content, highlighting its therapeutic potential for IBS via anti‐inflammatory pathways ...
Qingyang Yu +4 more
wiley +1 more source
Investigation of the mechanism of Yijing Decoction in the treatment of premature ovarian insufficiency: A network pharmacology study. [PDF]
Xu Y +6 more
europepmc +1 more source
Abstract Background Pain is often observed in patients with spasticity, but little is known about the relationship between pain and spasticity and the effectiveness of treating pain with botulinum toxins in these patients. Objective To explore onabotulinumtoxinA (onabotA) use and pain relief in patients with spasticity with pain at baseline.
Jörg Wissel +5 more
wiley +1 more source

